Clough Capital Partners L P Clovis Oncology, Inc. Transaction History

Clough Capital Partners L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $4.47 Million - $6.64 Million	-106,335 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $2.38 Million - $3.21 Million	-47,400 Reduced 30.83%	106,335 $5.61 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $4.04 Million - $5.92 Million	70,000 Added 83.6%	153,735 $10.5 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $5.62 Million - $7.1 Million	83,735	83,735 $6.9 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.